News
FDA approves first drug to fight severe forms of MS
March 30, 2017 /
Being diagnosed with multiple sclerosis (MS) is seen as a life sentence, as the disease can seriously affect a sufferer’s motor skills and cognitive abilities, but new hope might be on the way. This week, the US Food and Drug Administration (FDA) has approved a new drug, called ocrelizumab, which fights MS by targeting the body’s B cells and is the first to have an effect on the more severe form of the disease.
Michael Irving
MATR Supporters (view all)
Posted in: Cool Stuff That's Coming
Sorry, we couldn't find any posts. Please try a different search.